To further establish a role for ST6Gal-I in cisplatin sensitivity, ST6Gal-I expression was repressed by shRNA in Pa-1 ovarian cancer cells, a cell line with high endogenous levels of ST6Gal-I [13]. This evidence concerns the gene ST6GAL1 and ovarian carcinoma.